Back to
Man Group plc
PTGX
Showing 5 of 10 quarters
Position history for
Man Group plc's holdings in PROTAGONIST THERAPEUTICS INC
No. Man Group exited its PTGX (Protagonist Therapeutics) position in Q3 2025. Its Q2 2025 13F listed 34,013 shares worth $1.9M. Man Group first reported PTGX in Q2 2022 and held it in 8 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$2.5M
Total Shares Change
-55,831
Quarter-by-Quarter History